Help Your Patients Treat Nail Fungus While Maintaining a Healthy Environment
PROVEN EFFICACY AND CONVENIENCE
MANAGE THE ENVIRONMENT
IMPORTANT SAFETY INFORMATION
Ciclodan® is indicated in immunocompetent patients with mild to moderate onychomycosis without lunula involvement, due to Trichophyton rubrum. Ciclodan® is part of a comprehensive management program which includes removal of the unattached, infected nails as frequently as monthly by a health care professional. Health care professionals should determine whether patients with diabetes should trim their own nails. Since studies evaluating the concomitant use of systemic antifungals and Ciclodan® have not been conducted, concomitant use is not recommended at this time. Ciclodan® is generally well-tolerated: treatment-related side effects were periungual erythema (5%) and nail disorders (2%). Please see full prescribing information.
Medimetriks Pharmaceuticals, Inc.
383 Route 46 West
Fairfield, NJ 07004-2402 USA